鼻内针刺治疗变应性鼻炎的系统评价与Meta分析
与假针刺相比,鼻内针刺显著降低鼻部症状总分;与抗组胺药相比,鼻内针刺在鼻部非症状评分和生活质量方面更优,证据确定性多为低至中等,未见严重不良事件,但安全性报告不足。
要点
- 鼻内针刺可能改善变应性鼻炎症状和生活质量。
- 与假针刺比,鼻内针刺降低鼻部症状总分(MD -2.65)。
- 与抗组胺药比,鼻内针刺改善鼻部非症状评分和生活质量。
核心结论
- 鼻内针刺疗法可能有益于改善变应性鼻炎相关症状和生活质量,但安全性因报告不足尚不明确,需进一步高质量试验验证。
研究设计与样本
- 纳入单独或附加鼻内针刺治疗变应性鼻炎的随机对照试验,使用Cochrane偏倚风险2.0工具和GRADE方法评估质量。
主要发现
- 与假针刺相比,鼻内针刺显著降低鼻部症状总分(MD -2.65,95% CI -4.01至-1.29,1项RCT,30例,中等证据)。
- 与抗组胺药相比,鼻内针刺的鼻部非症状评分更低(MD -0.44,95% CI -0.64至-0.25,5项RCT,295例,中等证据)。
- 与抗组胺药相比,鼻内针刺在鼻结膜炎生活质量问卷评分上更优(MD -13.72,95% CI -18.01至-9.43,4项RCT,255例,中等证据)。
- 未报告严重不良事件,但安全性报告不充分。
临床怎么用
- 鼻内针刺可考虑作为变应性鼻炎的辅助治疗以改善症状和生活质量,但需注意安全性证据不足。
局限性
- 证据确定性普遍为低或中等。
- 安全性因报告不足尚不明确。
- 需要进一步高质量、严格设计且报告充分的试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Allergic rhinitis (AR) is a prevalent allergic condition affecting the nasal mucosa. Intranasal acupuncture therapy (IAT), an innovative therapy that involves the precise insertion of acupuncture needles into specific nasal acupoints, has demonstrated potential effects in managing AR. The aim of this study was to evaluate the effectiveness and safety of IAT in the management of AR. METHODS: Nine databases were systematically searched for randomized controlled trials (RCTs) from their inception to September 2024. We included participants who were diagnosed with AR and who received IAT alone or as add-on treatment to conventional treatment. The Cochrane risk of bias 2.0 tool and the GRADE approach were used to assess the quality of the studies. A meta-analysis was performed via RevMan 5.4.1 software. RESULTS: Twenty-one RCTs with 1889 participants were included. The certainty of evidence was generally low or moderate. Compared with sham acupuncture, the IAT significantly reduced the total nasal symptom score (MD -2.65, 95% CI -4.01 to -1.29, 1 RCT, 30 participants, moderate evidence). Compared to an antihistamine, IAT was associated with a lower total nasal non-symptom score (MD -0.44, 95% CI -0.64 to -0.25, 5 RCTs, 295 participants, moderate evidence) and a better quality of life measured by the rhinoconjunctivitis quality of life questionnaire (MD -13.72, 95% CI -18.01 to -9.43, 4 RCTs, 255 participants, moderate evidence). No serious adverse events were reported. CONCLUSION: The IAT may be beneficial for improving AR-related symptoms and quality of life. However, the safety of the IAT remains unclear due to inadequate reporting. Further high-quality, rigorously designed, and well-reported trials are needed. PROTOCOL REGISTRATION: PROSPERO, CRD42024526357.
引用
- Chen XY, Wang QY, Yan ZF, et al. Intranasal acupuncture therapy for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials. Integr Med Res. 2024. PMID: 40190741. doi:10.1016/j.imr.2024.101116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。